BMC Medical Co. Ltd. A - Asset Resilience Ratio

Latest as of June 2025: 55.90%

BMC Medical Co. Ltd. A (301367) has an Asset Resilience Ratio of 55.90% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read BMC Medical Co. Ltd. A total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥1.97 Billion
≈ $288.20 Million USD Cash + Short-term Investments

Total Assets

CN¥3.52 Billion
≈ $515.61 Million USD All company assets

Resilience Assessment

Very High
Financial Resilience Level

Asset Resilience Ratio Trend (2020–2024)

This chart shows how BMC Medical Co. Ltd. A's Asset Resilience Ratio has changed over time. See BMC Medical Co. Ltd. A book value and equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down BMC Medical Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is BMC Medical Co. Ltd. A worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥1.97 Billion 55.9%
Total Liquid Assets CN¥1.97 Billion 55.90%

Asset Resilience Insights

  • Very High Liquidity: BMC Medical Co. Ltd. A maintains exceptional liquid asset reserves at 55.90% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

BMC Medical Co. Ltd. A Industry Peers by Asset Resilience Ratio

Compare BMC Medical Co. Ltd. A's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087
Medical Instruments & Supplies 9.08%
Vizionfocus Inc.
TW:4771
Medical Instruments & Supplies 5.07%
Ansell Ltd
AU:ANN
Medical Instruments & Supplies 4.42%
Nanosonics Ltd
AU:NAN
Medical Instruments & Supplies 51.82%
SDI Ltd
AU:SDI
Medical Instruments & Supplies 6.36%
Austco Healthcare Ltd
AU:AHC
Medical Instruments & Supplies 15.90%
Trajan Group Holdings Ltd
AU:TRJ
Medical Instruments & Supplies 0.23%
Osteopore Ltd
AU:OSX
Medical Instruments & Supplies 43.09%

Annual Asset Resilience Ratio for BMC Medical Co. Ltd. A (2020–2024)

The table below shows the annual Asset Resilience Ratio data for BMC Medical Co. Ltd. A.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 66.74% CN¥2.29 Billion
≈ $334.47 Million
CN¥3.42 Billion
≈ $501.16 Million
+4.64pp
2023-12-31 62.10% CN¥1.81 Billion
≈ $265.22 Million
CN¥2.92 Billion
≈ $427.07 Million
-11.70pp
2022-12-31 73.80% CN¥2.16 Billion
≈ $316.08 Million
CN¥2.93 Billion
≈ $428.28 Million
+26.50pp
2021-12-31 47.30% CN¥295.00 Million
≈ $43.17 Million
CN¥623.69 Million
≈ $91.27 Million
+20.78pp
2020-12-31 26.52% CN¥124.00 Million
≈ $18.15 Million
CN¥467.64 Million
≈ $68.43 Million
--
pp = percentage points

About BMC Medical Co. Ltd. A

SHE:301367 China Medical Instruments & Supplies
Market Cap
$869.67 Million
CN¥5.94 Billion CNY
Market Cap Rank
#9752 Global
#2743 in China
Share Price
CN¥66.33
Change (1 day)
-1.38%
52-Week Range
CN¥64.34 - CN¥99.35
All Time High
CN¥225.96
About

BMC Medical Co., Ltd. researches, develops, manufactures, and supplies medical equipment and consumable in the field of respiratory health in China. It offers sleep-disordered breathing (SDB) diagnostic devices, non-invasive ventilators, high-flow nasal cannula oxygen therapy devices, oxygen concentrator, and respiratory consumables, such as various types of masks, breathing tubes, etc., as well … Read more